Healthcare
ProText Mobility, Inc.(TXTM)
Live Price
Offline$0.0059
-7.81% today
1Y Change
+39.13%
Window
Jun 23, 2025 → Jun 4, 2026
- Market Cap
- $10.00M
- Revenue Growth
- 0.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 0.0%
Coverage: 242 bars · Jun 23, 2025 → Jun 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ProText Mobility, Inc. (TXTM) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.01 and up 39.1% across the available one-year price window (Jun 23, 2025 → Jun 4, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Valuation already assumes a fairly strong business story at P/E 108.5. Stock Foundry combines TXTM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
P/E
Above sector median
108.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TXTM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TXTM Max Drawdown
-60.77%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TXTM and SPY.
Company Overview
ProText Mobility, Inc.
Other OTC
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.
- Leadership
- Dylon Du Plooy
- IPO Date
- Aug 19, 2003
- Employees
- 1
- Street Address
- 258 South Military Trail
- Mailing
- Deerfield Beach, FL, 33442
- Region
- Deerfield Beach, FL, US
- Reporting Currency
- USD
- Investor Line
- +1 202 621 1614
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 108.5
- EV/EBITDA
- —
- Price/Sales
- —
- Price/Book
- —
Growth
- Revenue
- 0.0%
- EPS
- 0.0%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 0.0%
- ROIC
- 0.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- —
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.